Log In
BCIQ
Print this Print this
 

IONIS-GSK4-LRx (formerly ISIS-GSK4-LRx, ISIS-GSK4Rx)

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense inhibitor against undisclosed target for an ophthalmic disease
Molecular Target
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat ocular disease
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today